EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE
Abroad (travel likely)Recruiting
Conditions
Epilepsy · Microbiota · Proteomics · Metabolomics · Biomarker Discovery
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Drottning Silvias Barnsjukhus, Gothenburg, Sweden
Contact: Study coordinator (Ann-Louise Esserlind, MD) · ann-louise.esserlind@vgregion.se · +46 31 343 63 00Universitetssjukhuset i Linköping, Linköping, Sweden
Contact: Study coordinator (Helena Gauffin, MD) · Helena.Gauffin@regionostergotland.se · +46 10 103 00 00Skånes universitetssjukhus, Lund, Sweden
Karolinska Universitetssjukhus, Stockholm, Sweden
Contact: Study coordinator (Sigrid Bjuresäter, Registered nurse) · sigrid.bjuresater@ki.se · +46 8 123 774 61Contact: Principal Investigator (Ronny Wickström, MD)Norrlands universitetssjukhus, Umeå, Sweden
Contact: Study coordinator (Måns Berglund, MD) · mans.berglund@regionvasterbotten.se · +46 90 785 91 40Akademiska Sjukhuset, Uppsala, Sweden
Study leads
Stefanie Prast-Nielsen, PhD
Study Director
Karolinska Institutet